Oxford COVID-19 vaccine generates immune response among young and old
Shortpedia
Content TeamImage Credit: Shortpedia
The COVID-19 vaccine being developed by Oxford University and AstraZeneca generates similar immune responses among younger and older adults, the pharmaceutical company has said. AstraZeneca said that the finding added to the body of evidence proving that the vaccine candidate is safe and effective. The development raises hopes as COVID-19 is known to severely affect older persons.